RHO and cancer: RHO‐ROCK pathway activation in cancer cells within the cSCC tumor mass further drives changes in the phenotype of tumor‐associated fibroblasts, and the consequent enhancement of collagen production, which stiffened the ECM and activated mechanotransduction signaling pathways within tumor cells, that promoted disease progression (Kular et al., 2015).